UK Markets closed

Tscan Therapeutics Inc (TCRX) CEO David P Southwell Bought $96,030 of Shares

- By insider

CEO of Tscan Therapeutics Inc (30-Year Financial, Insider Trades) David P Southwell (insider trades) bought 11,000 shares of TCRX on 09/08/2021 at an average price of $8.73 a share. The total cost of this purchase was $96,030.

For the complete insider trading history of TCRX, click here

.This article first appeared on GuruFocus.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting